We look forward to meeting with you at ASGCT 2021!
VGXI, Inc. is a leading contract manufacturer of DNA-based pharmaceuticals with over 20 years of experience providing exceptional quality GMP products for clients worldwide. Applications include DNA vaccines, immunotherapies, cell and gene therapy, gene editing, and mRNA production.
The company's skilled team has an outstanding track record of success in manufacturing challenging plasmid products under GMP conditions with exceptional yield, quality, and prompt delivery. Low-shear, highly efficient AIRMIX® lysis technology paired with VGXI's optimized purification process provides highly supercoiled plasmid material across production scales including for commercial indications.
A range of production services are available to meet each client's needs:
- High purity plasmid DNA preparations for pre-clinical research
- Highly Documented (HD) plasmid DNA manufacturing for use in GMP viral vector production or pharmacology / toxicology studies
- GMP plasmid DNA manufacturing for clinical through commercial supply
- Pre-clinical to GMP production of RNA including mRNA and lncRNA